Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
7.38
+0.13 (1.79%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Profound Medical Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Profound Medical stock has a consensus rating of "Strong Buy" and an average price target of $11.14. The average 1-year stock price forecast is 50.95% higher than the current stock price, while the lowest is $10 (+35.50%) and the highest is $12 (+62.60%).
Price Target: $11.14 (+50.95%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Profound Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Maintains $11 | Buy | Maintains | $11 | +49.05% | Jul 27, 2026 |
| Lake Street | Lake Street | Buy Reiterates $12 | Buy | Reiterates | $12 | +62.60% | Jul 7, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $12 → $10 | Buy | Reiterates | $12 → $10 | +35.50% | May 8, 2026 |
Financial Forecast
Revenue This Year
26.42M
from 16.10M
Increased by 64.11%
Revenue Next Year
44.73M
from 26.42M
Increased by 69.32%
EPS This Year
-0.85
from -1.41
EPS Next Year
-0.76
from -0.85
EPS and Forward PE are based on non-GAAP adjusted numbers.